Riverbridge Partners LLC Sells 3,372 Shares of Chemed Corporation $CHE

Key Points

• Riverbridge Partners LLC cut its Chemed stake by 6.2% in the first quarter, selling 3,372 shares and ending with 50,747 shares valued at about $19.2 million.
• Chemed reported better-than-expected quarterly earnings of $5.65 per share, topping estimates by $0.35, while revenue rose 1.6% year over year to $657.5 million.
• The company also paid a quarterly dividend of $0.60 per share, which annualizes to $2.40 and implies a modest yield of about 0.5%.

Riverbridge Partners LLC lowered its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 6.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 50,747 shares of the company's stock after selling 3,372 shares during the period. Riverbridge Partners LLC owned approximately 0.35% of Chemed worth $19,169,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of CHE. Monetary Solutions Ltd bought a new position in shares of Chemed in the fourth quarter worth approximately $25,000. Los Angeles Capital Management LLC purchased a new position in Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the 4th quarter worth approximately $27,000. Global Retirement Partners LLC increased its holdings in shares of Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock worth $37,000 after buying an additional 58 shares during the last quarter. Finally, Geneos Wealth Management Inc. raised its position in shares of Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock valued at $61,000 after buying an additional 76 shares in the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Trading Up 1.9%

CHE stock opened at $444.20 on Wednesday. The company has a market capitalization of $5.90 billion, a PE ratio of 24.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a one year low of $365.20 and a one year high of $562.77. The company's 50 day moving average price is $422.01 and its two-hundred day moving average price is $424.31.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to analysts' expectations of $659.22 million. During the same quarter in the prior year, the company earned $5.63 EPS. The firm's revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, analysts predict that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed's dividend payout ratio is presently 13.08%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares of the company's stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the firm's stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 3.33% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CHE. Oppenheimer dropped their price objective on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a report on Friday, February 27th. Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a research note on Monday, June 8th. Weiss Ratings upgraded Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, April 29th. Zacks Research raised Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. Finally, Royal Bank Of Canada upped their price objective on Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.